Stocks · News reference

Chardan Capital Initiates Coverage On Odysight ai with Buy Rating, Announces Price Target of $7.15

Aug 17, 2026, 11:56 AMBenzinga Newsdesk

Chardan Capital analyst James McIlree initiates coverage on Odysight ai (NASDAQ:ODYS) with a Buy rating and announces Price Target of $7.15.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 21, 2026, 12:50 PMSEC EDGAR
8-K filing — Odysight.ai Inc. (ODYS)
Filed: 2026-08-21 AccNo: 0001493152-26-039574 Size: 540 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
ODYS
BenzingaAug 20, 2026, 12:06 PMBenzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
BIVI CIRC EDSA HYPD IVF
BenzingaAug 20, 2026, 6:41 AMBenzinga Newsdesk
Odysight.ai Prices $11M Public Offering Of 3,437,500 Common Shares At $3.20 Per Share
ODYS
BenzingaAug 19, 2026, 9:07 PMBenzinga Newsdesk
Odysight.ai Launches A Proposed Confidentially Marketed Public Offering of Common Stock; No Size Disclosed
Odysight.ai Inc. (Nasdaq/TASE: ODYS) today announced that it has commenced a proposed confidentially marketed public offering (CMPO) of shares of its common stock. All shares in the offering are to be sold by the
ODYS